α-PVP
Discover related
2 sources
How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
Show:
| TripSit | Pharmacology | ||
|---|---|---|---|
| Classification | |||
| Class / category | — | ||
| Also known as | alpha-pvpapvpalpha-Pyrrolidinopentiophenoneflockaflakkaα-pvp | — | |
| Safety | |||
| Dose · Oral | |||
| Light | 5–10 mg | — | |
| Common | 10–25 mg | — | |
| Heavy | 25 mg+ | — | |
| Duration | |||
| Onset | 5–15 minutes | — | |
| Total | 2–5 hours | — | |
| After-effects | 1–48 hours | — | |
| Pharmacology | |||
| Receptor activity | — | Cytochrome P450 1B1UncheckedCytochrome P450 1A2AromataseCytochrome P450 1A1Adenosine receptor A1Adenosine receptor A2aSubstance-K receptorCytochrome P450 3A6 | |
TripSit summary
A potent, short-lasting pyrovalerone-type stimulant which became popular despite often being said to not be particularly euphoric, perhaps due to its propensity to cause compulsive redosing. Effects should be similar to MDPV.
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.